Target intelligence / Profile preview

Ras suppressor protein 1 (RSU1)

Target
RSU1
Molecular classification
Scaffold protein, Leucine-rich repeat (LRR)-containing protein, Adhesome family (focal adhesion complex component)[1][3][4][12], Other (no enzyme, receptor, transporter, or ion channel activity described)[4][9]
01

Overview

Ras suppressor protein 1 (RSU1) is an evolutionarily conserved, leucine-rich repeat (LRR) scaffold protein that participates in key cellular processes such as cell adhesion, migration, survival, growth inhibition, and differentiation[1][4][6][11]. RSU1 is localized at focal adhesions, where it stabilizes the PINCH1–ILK–Parvin complex (“IPP”), regulating integrin signaling and cytoskeletal dynamics[4][5][9]. Originally discovered as a suppressor of Ras-transforming activity, RSU1 modulates Ras-triggered signal transduction, frequently impacting the MAPK and JNK pathways[4]. Its role is complex in cancer, with evidence for both suppression of tumorigenesis and promotion of metastatic behavior, dependent on cellular context and isoform expression[1][2][5]. Alternative splicing of RSU1 yields truncated forms relevant to glioma pathology[1]. Despite its critical cellular role, RSU1 lacks catalytic activity and is being explored as a scaffold/adhesome target in anti-metastatic strategies, especially in liver and breast cancer settings[5]. Direct drug modulators of RSU1 are not known, but its expression and interaction partners may serve as novel biomarker or therapeutic avenues[5][11].

Other names
RSU1RSP1RSP-1Rsu-1FLJ31034Ras suppressor protein 1rsu-1
02

Mechanism of action

Experimental targeting approaches (anti-metastatic strategies in liver and breast cancer)[5]. Targeting RSU1 expression or RSU1–PINCH1 interaction to modulate cell adhesion and migration[1][4][5].

03

Biological functions

Cell adhesion (focal adhesion assembly and stabilization)[1][4][5]Signal transduction (primarily downstream of Ras signaling)[1][4][6][9][11][12]Regulation of cell migration and spreading[1][3][4][5][11]Regulation of cytoskeleton dynamics, especially actin organization[1][3][4]Growth inhibition[6][9][11]Nerve-growth factor–induced differentiation[6][9][10][11]Apoptosis modulation[1][3][4]Cell survival and proliferation regulation[1][4][11]
04

Disease associations

Cancer (roles in gliomas, breast cancer, lung adenocarcinoma, liver cancer, others)[1][2][3][5][4]Tumor metastasis (context-dependent, sometimes promoting, sometimes suppressing)[1][2][5]Potential involvement in immune response[4]
05

Safety considerations

No specific safety concerns documented, but as a scaffold protein essential for cell adhesion and survival signaling, improper targeting may risk impaired tissue integrity, unwanted apoptosis, or migration defects[4][5].
06

Interacting drugs

No specific drugs directly interacting with RSU1 identified in current literature[5][9][11]. RSU1 is being explored as a therapeutic target but with no direct ligands or approved drugs yet.
07

Biomarkers

RSU1 expression level as a prognostic marker in certain cancers (gliomas, breast, liver, lung)[5]Alternative splicing variants as disease markers, e.g., seen in high-grade gliomas[1][7]

Beyond the preview

Go deeper on Ras suppressor protein 1 (RSU1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras suppressor protein 1 (RSU1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call